Novo Nordisk

(NYSE) NVO

Current Price$42.55

Market Cap$135.74B

Since IPO (1981)+36,106%

5 Year+21%

1 Year-35%

1 Month+14%

Novo Nordisk Financials at a Glance

Market Cap

$135.74B

Revenue (TTM)

$309.06B

Net Income (TTM)

$102.43B

EPS (TTM)

$3.47

P/E Ratio

11.60

Dividend

$1.80

Beta (Volatility)

0.69 (Low)

Dividend

$1.80

Beta (Volatility)

0.69 (Low)

Price

$42.55

Volume

657,827

Open

$41.88

Price

$42.55

Volume

657,827

Open

$41.88

Previous Close

$40.29

Daily Range

$41.68 - $42.85

52-Week Range

$35.12 - $81.44

Dividend

$1.80

Beta (Volatility)

0.69 (Low)

Price

$42.55

Volume

657,827

Open

$41.88

Previous Close

$40.29

Daily Range

$41.68 - $42.85

52-Week Range

$35.12 - $81.44

NVO News

Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

David Jagielski, CPAMar 24, 2026

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

David Jagielski, CPAMar 20, 2026

Page 1

NVO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Novo Nordisk

Industry

Pharmaceuticals

Sector

Health Care

Employees

68,794

CEO

Maziar Mike Doustdar

Website

www.novonordisk.com

Headquarters

Bagsvaerd, 2880, DK

NVO Financials

Key Financial Metrics (TTM)

Gross Margin

81%

Operating Margin

41%

Net Income Margin

33%

Return on Equity

61%

Return on Capital

39%

Return on Assets

19%

Earnings Yield

8.62%

Dividend Yield

4.47%

Payout Ratio

50.53%

Stock Overview

Market Cap

$135.74B

Shares Outstanding

3.37B

Volume

657.83K

Avg. Volume

22.01M

Financials (TTM)

Gross Profit

$250.28B

Operating Income

$127.66B

EBITDA

$156.73B

Operating Cash Flow

$119.10B

Capital Expenditure

$90.11B

Free Cash Flow

$28.99B

Cash & ST Invst.

$26.96B

Total Debt

$130.96B

Novo Nordisk Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$79.14B

-7.6%

Gross Profit

$64.00B

-11.9%

Gross Margin

80.86%

N/A

Market Cap

$135.74B

N/A

Market Cap/Employee

$1.75M

N/A

Employees

77,406

N/A

Net Income

$26.89B

-4.7%

EBITDA

$37.30B

-18.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$104.00B

-36.0%

Accounts Receivable

$75.70B

-13.4%

Inventory

$49.62B

+21.5%

Long Term Debt

$118.94B

+32.6%

Short Term Debt

$12.02B

-8.4%

Return on Assets

18.87%

N/A

Return on Invested Capital

39.01%

N/A

Free Cash Flow

$36.22B

-750.8%

Operating Cash Flow

$7.62B

-38.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

PFEPfizer Inc.

PFEPfizer Inc.$26.75+1.85%

ABTAbbott Laboratories

ABTAbbott Laboratories$90.66-0.74%

SNYSanofi

SNYSanofi$46.69+1.43%

GILDGilead Sciences, Inc.

GILDGilead Sciences, Inc.$131.96+2.42%

GSKGSK plc

GSKGSK plc$52.32+1.79%

TMOThermo Fisher Scientific Inc.

TMOThermo Fisher Scientific Inc.$476.99+2.30%

AMGNAmgen Inc.

AMGNAmgen Inc.$348.63+3.14%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.48+0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$62.03+0.00%

MARAMara Holdings

MARAMara Holdings$12.07+0.13%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.59+0.09%

SOFISoFi Technologies

SOFISoFi Technologies$16.18+0.04%

OWLBlue Owl Capital

OWLBlue Owl Capital$9.84+0.11%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.25+0.03%

Questions About NVO

What is the current price of Novo Nordisk?

Novo Nordisk is trading at $42.55 per share.

What is the 52-week range for Novo Nordisk?

Over the past 52 weeks, Novo Nordisk has traded between $35.12 and $81.44.

How much debt does Novo Nordisk have?

As of the most recent reporting period, Novo Nordisk reported total debt of $20.59B.

How much cash does Novo Nordisk have on hand?

Novo Nordisk reported $4.16B in cash and cash equivalents in its most recent financial results.

What is Novo Nordisk’s dividend yield?

Novo Nordisk currently has a dividend yield of 4.47%.

Novo Nordisk

Novo Nordisk Financials at a Glance

NVO News

Is This Deal a Game Changer for Novo Nordisk?

Is Novo Nordisk's 72% Crash a Generational Buying Opportunity or a Value Trap?

Why Novo Nordisk's Pricing Shift Could Unlock a Much Larger Obesity Market

Could This New Approval Be a Turning Point For Novo Nordisk?

Novo Nordisk: A Strong Contender in the Pharmaceutical Arena

Can You Invest in Ozempic in 2026? Everything You Need to Know

Think Novo Nordisk Can't Keep Up in the GLP-1 Market? Its Latest Drug Approval Could Be a Game Changer

Down Near Its 5-Year Low, Is Novo Nordisk Stock Too Cheap to Pass Up?

NVO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Novo Nordisk

NVO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Novo Nordisk Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About NVO

What is the current price of Novo Nordisk?

What is the 52-week range for Novo Nordisk?

How much debt does Novo Nordisk have?

How much cash does Novo Nordisk have on hand?

What is Novo Nordisk’s dividend yield?

Premium Investing Services